TWD 96.3
(-0.82%)
Year | Eps | Eps Growth |
---|---|---|
2023 | 2.66 TWD | 24.3% |
2022 | 2.14 TWD | 38.96% |
2021 | 1.54 TWD | -20.21% |
2020 | 1.93 TWD | 4.89% |
2019 | 1.84 TWD | 26.03% |
2018 | 1.46 TWD | 421.43% |
2017 | 0.28 TWD | 163.64% |
2016 | -0.44 TWD | -148.89% |
2015 | 0.90 TWD | 350.0% |
2014 | -0.36 TWD | -148.0% |
2013 | 0.75 TWD | -36.44% |
2012 | 1.18 TWD | 18.0% |
2011 | 1.00 TWD | 725.0% |
2010 | -0.16 TWD | 87.3% |
2009 | -1.26 TWD | 0.0% |
Year | Eps | Eps Growth |
---|---|---|
2024 Q1 | 0.76 TWD | 31.03% |
2024 Q2 | 1.00 TWD | 31.58% |
2023 Q1 | 0.50 TWD | 11.11% |
2023 FY | - TWD | 24.3% |
2023 Q4 | 0.58 TWD | -28.4% |
2023 Q3 | 0.81 TWD | 5.19% |
2023 Q2 | 0.77 TWD | 54.0% |
2022 FY | - TWD | 38.96% |
2022 Q4 | 0.45 TWD | -34.78% |
2022 Q3 | 0.69 TWD | 15.0% |
2022 Q2 | 0.60 TWD | 46.34% |
2022 Q1 | 0.41 TWD | 7.89% |
2021 FY | - TWD | -20.21% |
2021 Q1 | 0.37 TWD | -31.48% |
2021 Q2 | 0.48 TWD | 29.73% |
2021 Q3 | 0.30 TWD | -37.5% |
2021 Q4 | 0.38 TWD | 26.67% |
2020 FY | - TWD | 4.89% |
2020 Q1 | 0.55 TWD | -8.33% |
2020 Q2 | 0.34 TWD | -38.18% |
2020 Q3 | 0.47 TWD | 38.24% |
2020 Q4 | 0.54 TWD | 14.89% |
2019 Q2 | 0.39 TWD | -17.02% |
2019 FY | - TWD | 26.03% |
2019 Q4 | 0.60 TWD | 53.85% |
2019 Q3 | 0.39 TWD | 0.0% |
2019 Q1 | 0.47 TWD | -9.62% |
2018 Q2 | 0.06 TWD | -89.93% |
2018 FY | - TWD | 421.43% |
2018 Q3 | 0.27 TWD | 339.74% |
2018 Q4 | 0.52 TWD | 92.59% |
2018 Q1 | 0.61 TWD | 60.53% |
2017 Q3 | 0.02 TWD | 0.0% |
2017 FY | - TWD | 163.64% |
2017 Q2 | 0.02 TWD | 148.04% |
2017 Q1 | -0.04 TWD | -109.94% |
2017 Q4 | 0.38 TWD | 2109.3% |
2016 Q2 | 0.01 TWD | 195.56% |
2016 Q3 | -0.82 TWD | -9634.88% |
2016 Q4 | 0.36 TWD | 143.9% |
2016 FY | - TWD | -148.89% |
2016 Q1 | -0.01 TWD | -105.0% |
2015 Q2 | 0.09 TWD | -60.91% |
2015 Q4 | 0.18 TWD | -56.1% |
2015 FY | - TWD | 350.0% |
2015 Q1 | 0.22 TWD | 151.16% |
2015 Q3 | 0.41 TWD | 376.74% |
2014 Q2 | 0.01 TWD | -50.0% |
2014 FY | - TWD | -148.0% |
2014 Q4 | -0.43 TWD | -1534.98% |
2014 Q3 | -0.03 TWD | -405.81% |
2014 Q1 | 0.02 TWD | -84.36% |
2013 Q2 | 0.17 TWD | 21.43% |
2013 Q4 | 0.11 TWD | -68.57% |
2013 FY | - TWD | -36.44% |
2013 Q1 | 0.14 TWD | -74.07% |
2013 Q3 | 0.35 TWD | 105.88% |
2012 Q4 | 0.54 TWD | 38.46% |
2012 Q3 | 0.39 TWD | 160.0% |
2012 Q1 | 0.11 TWD | -59.26% |
2012 Q2 | 0.15 TWD | 36.36% |
2012 FY | - TWD | 18.0% |
2011 Q3 | 0.29 TWD | 0.0% |
2011 FY | - TWD | 725.0% |
2011 Q4 | 0.27 TWD | -6.9% |
2011 Q2 | - TWD | 0.0% |
2010 FY | - TWD | 87.3% |
2010 Q4 | - TWD | 0.0% |
2009 FY | - TWD | 0.0% |
Name | Eps | Eps Difference |
---|---|---|
Nang Kuang Pharmaceutical Co., Ltd. | 1.96 TWD | -35.714% |
Maxigen Biotech Inc. | 1.86 TWD | -43.011% |
Bionime Corporation | 0.10 TWD | -2560.0% |
Pegavision Corporation | 22.83 TWD | 88.349% |
Visco Vision Inc. | 4.79 TWD | 44.468% |